Evaluación de la necesidad de preparados oficinales que requieren los pacientes atendidos en el Centro de Atención en Salud Integral (Tipo B) de la ESPOCH, Riobamba

Abstract

The main objective of this research study was to evaluate the need for Compounded medication required by patients treated at the Comprehensive Health Care Center type B, through descriptive and retrospective analysis. The study population consisted of 153 medical records of patients who attended the health unit in the period January 2021-May 2022. The investigation was carried out in three phases: identification of clinical histories of patients with skin problems, determination of possible compounded medication, and dissemination of the results to the medical, pharmaceutical, and administrative staff of the health unit. As result, it was obtained that dermatological pathologies were more prevalent in the female gender, who presented diseases such as mycosis (33.21%), contact dermatitis (33.85%), actinic dermatitis (1.54%), seborrheic dermatitis (1.54%), atopic dermatitis (21.54%) and warts (9.22%), for this reason, five pharmaceutical specialties were prescript for the treatment of different pathologies such as 1% clotrimazole cream, 1% terbinafine cream, urea 10%, acyclovir ointment 5%, and B-sitosterol (Mebo) 0.25%. The need to have compounded medication in the health unit was observed, to have formulations elaborated in the concentrations required by the patient, based on the Formulario Nacional de Medicamentos, pharmacopeias, among others. It was concluded that, in the pharmacy of the Comprehensive Health Care Center type B, there is a shortage of medicines, therefore, it is important to have compounded medication that adapts to the needs of patients and is an alternative to their pharmacological treatment. It is recommended to carry out a complete review of the medical records to identify other pathologies that require the formulation of compounded medications.